Bukit Uluwatu Villa Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bukit Uluwatu Villa Tbk trades at Rp850 (market cap 20.56T, 174.7M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bukit Uluwatu Villa Tbk is far larger — about 122.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bukit Uluwatu Villa Tbk is more actively traded (174.7M versus 71K). Which is the better fit depends on your goals.
| BUVA | OBAT | |
|---|---|---|
Market Cap | 20.56T | 167.37B |
Volume | 174.7M | 71K |
Lot | 1.75M | 710 |
Turnover | 149.55B | 17.51M |
Average Price | 856.05 | 246.63 |
Value | 149.55B | 17.51M |
Indicative Equilibrium Price | 850 | 246 |
Indicative Equilibrium Volume | 79.05K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukit Uluwatu Villa Tbk (the “Company”) was established in the Republic of Indonesia on December 15, 2000 based on the Notarial Deed No. 53 of Sugito Tedjamulja, S.H.. The Company’s status has been changed from foreign investment company (PMA) to domestic investment company (PMDN).
Read more on BUVA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →